Prelude Capital Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.17M | Buy |
|
|||||
|
2025
Q1 | $1.15M | Buy |
|
|||||
|
2024
Q4 | $950K | Buy |
|
|||||
|
2024
Q3 | $997K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $1.12M | Buy |
|
|||||
|
2023
Q4 | $984K | Buy |
|
|||||
|
2023
Q3 | $286K | Buy |
|
|||||
|
2023
Q2 | $296K | Buy |
|
|||||
|
2023
Q1 | $257K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $402K | Buy |
|
|||||
|
2020
Q2 | $262K | Buy |
|
|||||
|
2020
Q1 | $29K | Sell |
|
|||||
|
2019
Q4 | $84K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $1K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $315K | Sell |
|
|||||
|
2017
Q4 | $378K | Buy |
|
|||||
|
2017
Q3 | $519K | Buy |
|
|||||
|
2017
Q2 | $296K | Sell |
|
|||||
|
2017
Q1 | $320K | Buy |
|
|||||
|
2016
Q4 | $66K | Buy |
|
|||||
|
2016
Q3 | $27K | Buy |
|
|||||
|
2016
Q2 | $14K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $29K | Sell |
|
|||||
|
2015
Q3 | $62K | Buy |
|
|||||
|
2015
Q2 | $28K | Sell |
|
|||||
|
2015
Q1 | $42K | Sell |
|
|||||
|
2014
Q4 | $154K | Hold |
|
|||||
|
2014
Q3 | $68K | Buy |
|
|||||
|
2014
Q2 | $60K | Buy |
|
|||||
|
2014
Q1 | $19K | Sell |
|
|||||
|
2013
Q4 | $36K | Buy |
|